Tevogen Bio Holdings Inc. (TVGN)

NASDAQ: TVGN · Real-Time Price · USD

1.240

+0.060 (5.08%)

At close: Jun 27, 2025, 4:00 PM

1.238

-0.002 (-0.15%)

After-hours: Jun 27, 2025, 7:51 PM EDT

Tevogen Bio Holdings Employees

Tevogen Bio Holdings had 18 employees as of December 31, 2024.

Employees

18

Change

n/a

Growth

n/a

Revenue / Employee

n/a

Profits / Employee

-$1,738,041

Market Cap

228.03M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	18	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Abbott Laboratories	114,000
AstraZeneca	94,300
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000
AbbVie	55,000

Employee Rankings

TVGN News

10 days ago - Tevogen Updates on Development of EBV-Specific T Cell Therapy with Support from AI-Powered Target Discovery - GlobeNewsWire
19 days ago - Tevogen Expands Headquarters Amid Growth of AI and Generics & Biosimilars Initiatives - GlobeNewsWire
4 weeks ago - Tevogen Details its Artificial Intelligence Initiative, Tevogen.AI; Proprietary AI-Powered Immunotherapy with Microsoft and Databricks Partnerships - GlobeNewsWire
5 weeks ago - Tevogen Bio Plans to Expand Specialty Care Pipeline to Include Patients 65+, Building on Previous Forecast of Nearly $1 Billion in Launch-Year; Updated rNPV to Follow - GlobeNewsWire
5 weeks ago - Tevogen to Update on Robust Portfolio Assets, Business Expansion, Partnerships, Limited Tradable Float, High Insider Ownership and Strong Investor Confidence Ahead of June 23 Annual Meeting - GlobeNewsWire
6 weeks ago - Tevogen Bio's Business Model Addresses Biopharma Industry Challenges with Cost-Efficient Innovation - GlobeNewsWire
2 months ago - Tevogen to Share Direct Registration System (DRS) Process Details Following Increased Shareholder Interest - GlobeNewsWire
2 months ago - CD8 Technology Signs Letter of Intent for Tevogen Bio's In-House Manufacturing Facility, Marking First Phase of Up to $50 Million Commitment - GlobeNewsWire